Pharmacokinetics of Lumiracoxib in plasma and synovial fluid

Graham Scott,Christiane Rordorf,Christine Reynolds,Jyoti Kalbag,Michael Looby,Slavica Milosavljev,Margaret Weaver,John P. Huff,Dennis A. Ruff

Pharmacokinetics of Lumiracoxib in plasma and synovial fluid

2004

Graham Scott
Christiane Rordorf
Christine Reynolds
Jyoti Kalbag
Michael Looby
Slavica Milosavljev
Margaret Weaver
John P. Huff
Dennis A. Ruff

Background umiracoxib is a new cyclo-oxygenase-2 (COX-2) selective inhibitor in development for the treatment of rheumatoid arthritis, osteoarthritis and acute pain.

Keywords:

Anesthesia
Tiaprofenic acid
Osteoarthritis
Etodolac
Rheumatoid arthritis
Tenoxicam
Immunology
Synovial fluid
Medicine
Pharmacokinetics
Lumiracoxib
Pharmacology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations